<SEC-DOCUMENT>0000899243-23-008752-index.html : 20230316
<SEC-HEADER>0000899243-23-008752.hdr.sgml : 20230316
<ACCEPTANCE-DATETIME>20230316175237
ACCESSION NUMBER:		0000899243-23-008752
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230314
FILED AS OF DATE:		20230316
DATE AS OF CHANGE:		20230316

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KIRSKE DAVID
		CENTRAL INDEX KEY:			0001276750

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28386
		FILM NUMBER:		23740034

	MAIL ADDRESS:	
		STREET 1:		C/O CTI BIOPHARMA CORP.
		STREET 2:		3101 WESTERN AVE., SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CTI BIOPHARMA CORP
		CENTRAL INDEX KEY:			0000891293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911533912
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 800
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		2062827100

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 800
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	19960321
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>